Sona Nanotech Receives CE Mark Approval for its Rapid COVID-19 Antigen Test

Stock Information for Sona Nanotech Inc - Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sona Nanotech Inc - Ordinary Shares

Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study
Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development
Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results
Sona Nanotech Announces Filing of Provisional Patent Application
Sona Nanotech Grants Options
Sona Nanotech Announces Director Retirement
Sona Nanotech Closes Private Placement Financing to Raise $750,000 in Gross Proceeds and Announces Additional Financing
Sona Nanotech Arranges Brokered Private Placement Financing

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.